Shares of Sunshine Heart Inc (NASDAQ:CHFS) saw an uptick in trading volume on Friday . 2,884,595 shares changed hands during mid-day trading, an increase of 304% from the previous session’s volume of 713,246 shares.The stock last traded at $3.89 and had previously closed at $3.58.
A number of brokerages recently issued reports on CHFS. Zacks Investment Research cut shares of Sunshine Heart from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. ValuEngine upgraded shares of Sunshine Heart from a “strong sell” rating to a “sell” rating in a report on Tuesday, October 31st.
Sunshine Heart (NASDAQ:CHFS) last issued its quarterly earnings data on Tuesday, October 31st. The company reported ($4.55) earnings per share (EPS) for the quarter. Sunshine Heart had a negative return on equity of 165.61% and a negative net margin of 263.73%. equities research analysts predict that Sunshine Heart Inc will post -3.03 EPS for the current fiscal year.
Sunshine Heart Company Profile
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with MarketBeat.com's FREE daily email newsletter.